Search

Your search keyword '"Merli, Pietro"' showing total 634 results

Search Constraints

Start Over You searched for: Author "Merli, Pietro" Remove constraint Author: "Merli, Pietro"
634 results on '"Merli, Pietro"'

Search Results

1. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID

2. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

3. Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study

4. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

5. A Day 14 Endpoint for Acute GVHD Clinical Trials

6. TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

7. Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome

8. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

9. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

10. Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL

12. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

13. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

15. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

16. Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

17. Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis.

18. TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders

19. Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients

23. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III

24. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

25. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis

26. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)

27. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

28. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

30. The utility of biomarkers in acute GVHD prognostication

31. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy

32. Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers

34. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as predictor of mortality in children

35. Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies

36. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion

37. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease

38. Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL

39. GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

40. Data from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

41. Supplementary Data from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

42. Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor

43. The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors

44. Neutralization of IFNγ improves the safety profile of CAR T-cells while maintaining unaffected efficacy against B-cell malignancies

46. Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT

47. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders

48. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd

49. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients

50. Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors

Catalog

Books, media, physical & digital resources